| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99284 |
Emergency department visit for the evaluation and management, high severity |
8,969 |
8,534 |
$4.80M |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
12,831 |
12,364 |
$3.71M |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
3,277 |
3,000 |
$2.10M |
| 87636 |
Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B |
5,884 |
5,665 |
$1.00M |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
3,448 |
3,355 |
$277K |
| 71045 |
Radiologic examination, chest; single view |
2,116 |
1,990 |
$130K |
| 80053 |
Comprehensive metabolic panel |
7,145 |
6,505 |
$116K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
7,977 |
7,148 |
$85K |
| 71046 |
Radiologic examination, chest; 2 views |
684 |
649 |
$69K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
1,017 |
918 |
$57K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
2,911 |
2,772 |
$51K |
| 42820 |
Tonsillectomy and adenoidectomy; younger than age 12 |
25 |
22 |
$46K |
| J7050 |
Infusion, normal saline solution, 250 cc |
647 |
473 |
$40K |
| 87807 |
|
1,147 |
1,118 |
$38K |
| 11042 |
Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm |
293 |
124 |
$34K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
1,010 |
852 |
$30K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
797 |
693 |
$25K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
2,458 |
1,680 |
$18K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
59 |
52 |
$15K |
| 70450 |
Computed tomography, head or brain; without contrast material |
254 |
246 |
$14K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
290 |
260 |
$14K |
| 86738 |
|
460 |
447 |
$13K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
53 |
52 |
$11K |
| 81001 |
|
1,899 |
1,766 |
$9K |
| 87430 |
|
1,826 |
1,780 |
$8K |
| C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
218 |
208 |
$7K |
| 59025 |
Fetal non-stress test |
50 |
43 |
$6K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
54 |
51 |
$6K |
| 81003 |
|
921 |
681 |
$5K |
| 69436 |
Tympanostomy (requiring insertion of ventilating tube), general anesthesia |
13 |
12 |
$3K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
18 |
18 |
$3K |
| 84484 |
|
734 |
570 |
$3K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
364 |
328 |
$3K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
1,037 |
910 |
$2K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
388 |
377 |
$2K |
| 31231 |
|
13 |
12 |
$2K |
| 81025 |
|
100 |
90 |
$2K |
| 30802 |
|
17 |
14 |
$2K |
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
73 |
72 |
$1K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
204 |
193 |
$1K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
693 |
556 |
$1K |
| 83735 |
|
275 |
231 |
$1K |
| 83880 |
|
82 |
79 |
$1K |
| 87632 |
|
14 |
14 |
$838.64 |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
154 |
139 |
$763.03 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
709 |
650 |
$750.79 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
180 |
164 |
$589.98 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
139 |
135 |
$521.66 |
| 83605 |
|
75 |
68 |
$502.15 |
| 74018 |
|
13 |
12 |
$479.01 |
| 83690 |
|
64 |
53 |
$280.68 |
| 87186 |
|
58 |
55 |
$249.31 |
| 87077 |
|
56 |
53 |
$218.00 |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
55 |
55 |
$165.15 |
| 80048 |
Basic metabolic panel (calcium, ionized) |
45 |
42 |
$143.17 |
| 87040 |
|
42 |
24 |
$129.95 |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
12 |
12 |
$123.80 |
| 85379 |
|
13 |
13 |
$107.89 |
| A9270 |
Non-covered item or service |
884 |
774 |
$88.28 |
| 87070 |
|
13 |
12 |
$60.27 |
| 85610 |
|
13 |
13 |
$37.30 |
| J1170 |
Injection, hydromorphone, up to 4 mg |
14 |
14 |
$37.28 |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
16 |
13 |
$36.72 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
38 |
35 |
$12.57 |
| J2704 |
Injection, propofol, 10 mg |
32 |
29 |
$0.00 |
| J7040 |
Infusion, normal saline solution, sterile (500 ml = 1 unit) |
26 |
24 |
$0.00 |
| 94664 |
|
13 |
13 |
$0.00 |
| J0171 |
Injection, adrenalin, epinephrine, 0.1 mg |
17 |
17 |
$0.00 |